Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 13,415	$ 5,747
Accounts receivable, net	57	158
Prepaid expenses and other current assets	2,049	939
Current deposits	100	371
Total current assets	15,621	7,215
Property and equipment, net	278	367
Operating lease right-of-use assets	402	482
Long-term investments	9,173	6,725
Total assets	25,474	14,789
Current liabilities:
Accounts payable and accrued expenses	8,023	6,120
Current portion of operating lease liabilities	184	155
Current portion of contract liabilities	35	31
Current portion of notes payable	256	84
Total current liabilities	8,498	6,390
Contract liabilities, net of current portion		1,009
Operating lease liabilities, net of current portion	492	676
Warrant liability, related party	1,262	2,871
Other liabilities		50
Total liabilities	10,252	10,996
Commitments and contingencies
Redeemable noncontrolling interest	24,962	83,895
Stockholders’ deficit:
Additional paid-in capital	238,193	209,161
Accumulated deficit	(248,834)	(290,036)
Total stockholders’ deficit attributable to vTv Therapeutics Inc.	(9,740)	(80,102)
Total liabilities, redeemable noncontrolling interest and stockholders’ deficit	25,474	14,789
Class A Common Stock [Member]
Stockholders’ deficit:
Common stock value	669	541
Class B Common Stock [Member]
Stockholders’ deficit:
Common stock value	$ 232	$ 232